Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction
The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF). HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among...
Saved in:
| Published in: | Journal of the American College of Cardiology Vol. 58; no. 3; p. 265 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
12.07.2011
|
| Subjects: | |
| ISSN: | 1558-3597, 1558-3597 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF).
HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood.
Left ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls.
In HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005).
Both reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients. |
|---|---|
| AbstractList | The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF).OBJECTIVESThe purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF).HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood.BACKGROUNDHFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood.Left ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls.METHODSLeft ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls.In HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005).RESULTSIn HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005).Both reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients.CONCLUSIONSBoth reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients. The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved ejection fraction (HFPEF). HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood. Left ventricular volumes (2-dimensional echocardiography), cardiac output, Vo(2), and calculated arterial-venous oxygen content difference (A-Vo(2) Diff) were measured at rest and during incremental, exhaustive upright cycle exercise in 48 HFPEF patients (age 69 ± 6 years) and 25 healthy age-matched controls. In HFPEF patients compared with healthy controls, Vo(2) was reduced at peak exercise (14.3 ± 0.5 ml·kg·min(-1) vs. 20.4 ± 0.6 ml·kg·min(-1); p < 0.0001) and was associated with a reduced peak cardiac output (6.3 ± 0.2 l·min(-1) vs. 7.6 ± 0.2 l·min(-1); p < 0.0001) and A-Vo(2) Diff (17 ± 0.4 ml·dl(-1) vs. 19 ± 0.4 ml·dl(-1), p < 0.0007). The strongest independent predictor of peak Vo(2) was the change in A-Vo(2) Diff from rest to peak exercise (A-Vo(2) Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized β coefficient, 0.66; p = 0.0002) and healthy controls (partial correlate, 0.61; standardized β coefficient, 0.41; p = 0.005). Both reduced cardiac output and A-Vo(2) Diff contribute significantly to the severe exercise intolerance in elderly HFPEF patients. The finding that A-Vo(2) Diff reserve is an independent predictor of peak Vo(2) suggests that peripheral, noncardiac factors are important contributors to exercise intolerance in these patients. |
| Author | Kitzman, Dalane W Haykowsky, Mark J John, Jerry M Brubaker, Peter H Morgan, Timothy M Stewart, Kathryn P |
| Author_xml | – sequence: 1 givenname: Mark J surname: Haykowsky fullname: Haykowsky, Mark J organization: Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Alberta, Canada – sequence: 2 givenname: Peter H surname: Brubaker fullname: Brubaker, Peter H – sequence: 3 givenname: Jerry M surname: John fullname: John, Jerry M – sequence: 4 givenname: Kathryn P surname: Stewart fullname: Stewart, Kathryn P – sequence: 5 givenname: Timothy M surname: Morgan fullname: Morgan, Timothy M – sequence: 6 givenname: Dalane W surname: Kitzman fullname: Kitzman, Dalane W |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21737017$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkD1PwzAYhC1URD_gDzAgb0wJthPbyYjKp1SJBebI2K-po8QptgP039NCkZju0enuhpujiR88IHROSU4JFVdt3iqtc0YozQnLCedHaEY5r7KC13Lyj6doHmNLCBEVrU_QlFFZSELlDL3dQILQO698iniwGL4gaBcBO5-GDoLyes8YOgOh2-I1qJCwVa4bA-CNSg72zU-X1ngTIEL4AIOhBZ3c4LEN6gdO0bFVXYSzgy7Qy93t8_IhWz3dPy6vV5kWRKas5NpQ0CUFK6kxlkFhia10LUDWpa4tKQtdKWU4F6oShEtuhawpMTvfUsoW6PJ3dxOG9xFianoXNXSd8jCMsakkl4zxUuySF4fk-NqDaTbB9Spsm79v2Dczu2tY |
| CitedBy_id | crossref_primary_10_3389_fmed_2021_692029 crossref_primary_10_1001_jama_2023_0675 crossref_primary_10_1016_j_cjca_2025_03_015 crossref_primary_10_1016_j_ijcard_2013_05_006 crossref_primary_10_1016_j_echo_2015_06_004 crossref_primary_10_1016_j_ijcard_2016_07_135 crossref_primary_10_1161_CIRCRESAHA_119_313572 crossref_primary_10_2217_fca_2017_0023 crossref_primary_10_3390_jcm12134438 crossref_primary_10_1016_j_ijcard_2025_133320 crossref_primary_10_1016_j_jacc_2014_05_030 crossref_primary_10_3390_biomedicines12112589 crossref_primary_10_1152_japplphysiol_00374_2015 crossref_primary_10_1016_j_jjcc_2021_11_003 crossref_primary_10_1161_CIRCHEARTFAILURE_117_004129 crossref_primary_10_1161_CIRCHEARTFAILURE_112_966564 crossref_primary_10_1161_CIRCULATIONAHA_119_041818 crossref_primary_10_1007_s11897_013_0166_4 crossref_primary_10_1007_s10741_022_10259_1 crossref_primary_10_1016_j_ccl_2016_06_001 crossref_primary_10_1016_j_hrtlng_2021_02_004 crossref_primary_10_1152_japplphysiol_00013_2019 crossref_primary_10_1016_j_jbmt_2024_03_065 crossref_primary_10_5339_gcsp_2014_40 crossref_primary_10_1002_ehf2_14070 crossref_primary_10_1016_j_jacc_2012_02_055 crossref_primary_10_1155_2024_2735577 crossref_primary_10_3390_jcdd9080241 crossref_primary_10_1016_j_jchf_2017_10_014 crossref_primary_10_5339_gcsp_2015_12 crossref_primary_10_1016_j_pcad_2016_06_002 crossref_primary_10_1016_j_jcmg_2018_10_039 crossref_primary_10_1007_s10741_017_9603_x crossref_primary_10_1007_s10741_025_10504_3 crossref_primary_10_1177_2040622313480382 crossref_primary_10_3389_fcvm_2023_1098395 crossref_primary_10_1111_eci_13261 crossref_primary_10_1152_ajpregu_00290_2018 crossref_primary_10_1161_CIRCHEARTFAILURE_114_001825 crossref_primary_10_3389_fcvm_2024_1431787 crossref_primary_10_4081_cardio_2025_67 crossref_primary_10_1016_j_amjcard_2024_09_005 crossref_primary_10_1007_s11886_014_0501_8 crossref_primary_10_1016_j_jacc_2013_10_007 crossref_primary_10_1016_j_jsha_2012_01_004 crossref_primary_10_1161_CIRCRESAHA_118_312669 crossref_primary_10_1007_s10741_021_10114_9 crossref_primary_10_1016_j_cpcardiol_2015_12_002 crossref_primary_10_1016_j_jchf_2015_05_010 crossref_primary_10_1097_HCO_0b013e3283512035 crossref_primary_10_1152_ajpheart_00414_2017 crossref_primary_10_1155_2013_130724 crossref_primary_10_1007_s11936_012_0187_4 crossref_primary_10_1007_s12265_025_10699_8 crossref_primary_10_1016_j_jchf_2018_03_003 crossref_primary_10_1249_MSS_0000000000000388 crossref_primary_10_5507_bp_2014_066 crossref_primary_10_1016_j_jacc_2015_07_067 crossref_primary_10_1161_CIRCHEARTFAILURE_114_001915 crossref_primary_10_1016_j_hfc_2014_08_009 crossref_primary_10_1016_j_lfs_2024_122594 crossref_primary_10_1016_j_cardfail_2021_04_013 crossref_primary_10_1097_CRD_0000000000000454 crossref_primary_10_1002_ejhf_2747 crossref_primary_10_1007_s11936_021_00904_7 crossref_primary_10_1161_JAHA_121_024582 crossref_primary_10_1152_japplphysiol_00798_2022 crossref_primary_10_1093_eurjcn_zvac004 crossref_primary_10_1016_j_ijcard_2014_11_106 crossref_primary_10_1093_eurjpc_zwae332 crossref_primary_10_1007_s11897_012_0087_7 crossref_primary_10_1016_j_jacc_2013_02_013 crossref_primary_10_1161_CIRCULATIONAHA_115_017119 crossref_primary_10_1161_CIRCHEARTFAILURE_122_010003 crossref_primary_10_1186_s13643_024_02529_w crossref_primary_10_1016_j_jacc_2023_01_049 crossref_primary_10_1177_2047487317706587 crossref_primary_10_3390_jcdd9030087 crossref_primary_10_7556_jaoa_2015_089 crossref_primary_10_1016_j_jacc_2013_04_033 crossref_primary_10_1002_jmri_25379 crossref_primary_10_1016_j_amjmed_2018_07_009 crossref_primary_10_1016_j_cjca_2016_06_001 crossref_primary_10_1111_jgs_16050 crossref_primary_10_1152_japplphysiol_00049_2015 crossref_primary_10_1016_j_cjca_2018_08_012 crossref_primary_10_1016_j_ijcard_2017_10_114 crossref_primary_10_1161_JAHA_114_001293 crossref_primary_10_1161_CIRCULATIONAHA_115_018954 crossref_primary_10_1093_eurjpc_zwae363 crossref_primary_10_3389_fcvm_2025_1598878 crossref_primary_10_1016_j_hrtlng_2022_03_013 crossref_primary_10_1016_j_jcmg_2017_08_021 crossref_primary_10_3389_fcvm_2021_631807 crossref_primary_10_1016_j_bbadis_2021_166208 crossref_primary_10_1007_s00395_024_01034_4 crossref_primary_10_1177_2047487315622093 crossref_primary_10_1007_s10741_023_10309_2 crossref_primary_10_1016_j_jacc_2019_01_072 crossref_primary_10_1016_j_jacc_2011_09_015 crossref_primary_10_1016_j_cardfail_2024_06_007 crossref_primary_10_1016_j_hfc_2017_02_012 crossref_primary_10_1152_japplphysiol_00747_2017 crossref_primary_10_1152_japplphysiol_00918_2023 crossref_primary_10_1016_j_hfc_2014_04_001 crossref_primary_10_1007_s11886_020_01318_w crossref_primary_10_1002_ejhf_1739 crossref_primary_10_1016_j_chest_2019_04_109 crossref_primary_10_1016_j_jacc_2017_09_006 crossref_primary_10_1161_CIRCHEARTFAILURE_123_011693 crossref_primary_10_1161_CIRCHEARTFAILURE_117_004281 crossref_primary_10_1016_j_jacc_2011_11_062 crossref_primary_10_1016_j_cger_2016_01_002 crossref_primary_10_1016_j_jacc_2016_04_052 crossref_primary_10_1111_echo_12928 crossref_primary_10_1161_CIRCHEARTFAILURE_117_003862 crossref_primary_10_1161_JAHA_116_003248 crossref_primary_10_1038_s41598_022_09637_4 crossref_primary_10_1016_j_exger_2021_111626 crossref_primary_10_1097_HCO_0b013e32835164e3 crossref_primary_10_1016_j_hlc_2017_07_002 crossref_primary_10_1038_s41598_023_31381_6 crossref_primary_10_1016_j_jchf_2025_02_024 crossref_primary_10_1016_j_cardfail_2024_01_015 crossref_primary_10_1111_chf_12013 crossref_primary_10_1097_PHM_0000000000000312 crossref_primary_10_3390_ijms23158631 crossref_primary_10_2196_resprot_8865 crossref_primary_10_1113_EP088835 crossref_primary_10_1186_s40798_024_00740_6 crossref_primary_10_1002_ejhf_2146 crossref_primary_10_1007_s10741_022_10219_9 crossref_primary_10_1016_j_chest_2023_06_019 crossref_primary_10_1016_j_jcmg_2018_12_034 crossref_primary_10_1161_CIRCHEARTFAILURE_114_001551 crossref_primary_10_1016_j_amjcard_2021_03_011 crossref_primary_10_1002_ejhf_239 crossref_primary_10_1016_j_jacc_2015_10_096 crossref_primary_10_1161_JAHA_116_005434 crossref_primary_10_1161_CIRCHEARTFAILURE_120_007198 crossref_primary_10_1002_ejhf_1059 crossref_primary_10_1002_ejhf_913 crossref_primary_10_1097_CRD_0000000000000416 crossref_primary_10_1161_CIRCULATIONAHA_119_041886 crossref_primary_10_3389_fcvm_2022_1016452 crossref_primary_10_1093_eurheartj_ehw241 crossref_primary_10_1111_echo_13440 crossref_primary_10_1161_JAHA_120_016635 crossref_primary_10_1038_s41598_021_03974_6 crossref_primary_10_1159_000350068 crossref_primary_10_1113_JP280899 crossref_primary_10_23736_S1824_4785_17_02930_2 crossref_primary_10_1111_chf_12005 crossref_primary_10_1161_CIRCULATIONAHA_117_029058 crossref_primary_10_1016_j_ahj_2012_09_002 crossref_primary_10_1016_j_cardfail_2012_06_530 crossref_primary_10_1016_j_jchf_2019_01_006 crossref_primary_10_1016_j_ijcard_2012_03_093 crossref_primary_10_1016_j_cardfail_2014_07_010 crossref_primary_10_1186_s12933_023_01835_2 crossref_primary_10_1007_s11897_018_0383_y crossref_primary_10_1016_j_rehab_2012_03_005 crossref_primary_10_1002_ejhf_3105 crossref_primary_10_1038_nrcardio_2014_83 crossref_primary_10_1016_j_cardfail_2019_02_015 crossref_primary_10_1016_j_jacc_2021_07_014 crossref_primary_10_3389_fphys_2022_967817 crossref_primary_10_1161_CIRCULATIONAHA_116_021884 crossref_primary_10_1016_j_ihj_2021_06_012 crossref_primary_10_1016_j_ahj_2014_08_010 crossref_primary_10_1016_j_jchf_2015_07_005 crossref_primary_10_1016_j_hfc_2014_03_001 crossref_primary_10_1152_japplphysiol_00045_2023 crossref_primary_10_1186_s12872_022_02792_6 crossref_primary_10_1161_CIRCULATIONAHA_114_014420 crossref_primary_10_1016_j_jacadv_2024_101101 crossref_primary_10_1002_ejhf_1956 crossref_primary_10_1016_j_jchf_2020_03_008 crossref_primary_10_1186_s12933_018_0688_x crossref_primary_10_1016_j_cjco_2025_01_004 crossref_primary_10_1016_j_amjcard_2016_10_026 crossref_primary_10_1016_j_ccl_2021_12_009 crossref_primary_10_1016_j_cardfail_2016_10_007 crossref_primary_10_1016_j_jacc_2023_02_012 crossref_primary_10_1161_CIR_0000000000001122 crossref_primary_10_1007_s11897_015_0257_5 crossref_primary_10_2217_fca_2021_0135 crossref_primary_10_1177_2047487316668150 crossref_primary_10_1007_s00392_018_1344_x crossref_primary_10_1016_j_jacc_2013_10_063 crossref_primary_10_1016_j_cjca_2015_12_021 crossref_primary_10_1161_CIRCHEARTFAILURE_112_000216 crossref_primary_10_1016_j_cardfail_2021_10_010 crossref_primary_10_1161_CIRCHEARTFAILURE_117_004750 crossref_primary_10_1093_eurjcn_zvac096 crossref_primary_10_1161_CIRCHEARTFAILURE_124_012512 crossref_primary_10_1007_s11886_018_1056_x crossref_primary_10_1007_s40256_017_0219_2 crossref_primary_10_1016_j_jcmg_2022_12_009 crossref_primary_10_1113_EP090674 crossref_primary_10_1161_CIRCIMAGING_116_005467 crossref_primary_10_5339_gcsp_2012_10 crossref_primary_10_3390_jcm11102692 crossref_primary_10_1093_eurheartj_eht117 crossref_primary_10_1007_s11897_016_0277_9 crossref_primary_10_1111_echo_15648 crossref_primary_10_1111_echo_14799 crossref_primary_10_1016_j_ccl_2022_06_001 crossref_primary_10_1016_j_ccl_2022_06_003 crossref_primary_10_1016_j_hfc_2019_08_008 crossref_primary_10_1016_j_cardfail_2015_11_004 crossref_primary_10_1016_j_jacc_2011_02_054 crossref_primary_10_1007_s10741_022_10233_x crossref_primary_10_1093_eurjhf_hft026 crossref_primary_10_1161_CIRCULATIONAHA_122_061828 crossref_primary_10_1016_j_cardfail_2014_01_005 crossref_primary_10_1161_CIRCHEARTFAILURE_112_967919 crossref_primary_10_1007_s10741_025_10545_8 crossref_primary_10_1002_ejhf_2337 crossref_primary_10_1161_JAHA_121_026009 crossref_primary_10_1016_j_ahj_2016_01_002 crossref_primary_10_1016_j_ccl_2022_06_010 crossref_primary_10_3390_ijerph19020709 crossref_primary_10_1016_j_jchf_2016_06_002 crossref_primary_10_1038_s41598_024_61529_x crossref_primary_10_1002_ejhf_184 crossref_primary_10_1007_s10741_019_09853_7 crossref_primary_10_3389_fcvm_2021_678614 crossref_primary_10_1155_2017_4865756 crossref_primary_10_1161_CIRCULATIONAHA_117_031528 crossref_primary_10_1016_j_chest_2020_05_552 crossref_primary_10_1152_ajpheart_00469_2015 crossref_primary_10_1016_j_jchf_2016_03_022 crossref_primary_10_1016_j_jjcc_2023_06_014 crossref_primary_10_1111_jch_13210 crossref_primary_10_1111_jgs_14940 crossref_primary_10_1161_CIRCRESAHA_125_325531 crossref_primary_10_1016_j_jacc_2011_08_048 crossref_primary_10_1161_CIRCRESAHA_125_325534 crossref_primary_10_1097_HCO_0000000000000824 crossref_primary_10_1113_EP086275 crossref_primary_10_1161_CIRCHEARTFAILURE_112_969071 crossref_primary_10_1161_CIRCHEARTFAILURE_118_004969 crossref_primary_10_3390_nu12010211 crossref_primary_10_1016_j_yjmcc_2015_02_025 crossref_primary_10_1016_j_crphys_2025_100153 crossref_primary_10_1007_s10147_018_1315_2 crossref_primary_10_1161_CIRCULATIONAHA_118_036259 crossref_primary_10_1186_s12933_021_01314_6 crossref_primary_10_1001_jama_2023_1053 crossref_primary_10_1007_s00421_019_04222_6 crossref_primary_10_1161_CIRCHEARTFAILURE_114_001192 crossref_primary_10_1136_heartjnl_2019_314797 crossref_primary_10_1186_s40959_019_0038_5 crossref_primary_10_4081_cardio_2025_71 crossref_primary_10_1016_j_apmr_2016_08_481 crossref_primary_10_3389_fphys_2020_572355 crossref_primary_10_1097_HCR_0000000000000459 crossref_primary_10_1186_s40814_024_01580_7 crossref_primary_10_3390_jcm12185817 crossref_primary_10_1002_ejhf_2313 crossref_primary_10_1016_j_metabol_2019_05_007 crossref_primary_10_1016_j_jacc_2022_07_011 crossref_primary_10_1016_j_jacc_2011_12_013 crossref_primary_10_1007_s10741_018_9714_z crossref_primary_10_1016_j_cardfail_2021_02_011 crossref_primary_10_1016_j_jjcc_2022_09_004 crossref_primary_10_1097_CRD_0000000000000124 crossref_primary_10_1007_s00395_022_00958_z crossref_primary_10_1016_j_jacc_2011_07_024 crossref_primary_10_1016_j_jacc_2012_04_012 crossref_primary_10_1002_phy2_174 crossref_primary_10_1016_j_jacc_2020_10_022 crossref_primary_10_1007_s11897_018_0408_6 crossref_primary_10_1016_j_cpcardiol_2019_03_006 crossref_primary_10_1016_j_amjcard_2012_08_015 crossref_primary_10_1097_PHM_0000000000001125 crossref_primary_10_3390_jcm12093341 crossref_primary_10_1016_j_jacc_2015_11_045 crossref_primary_10_1097_JCN_0000000000000982 crossref_primary_10_1152_japplphysiol_01127_2014 crossref_primary_10_1371_journal_pone_0255682 crossref_primary_10_1016_j_jcmg_2023_06_014 crossref_primary_10_1161_CIRCIMAGING_112_980037 crossref_primary_10_1111_echo_13709 crossref_primary_10_1016_j_amjcard_2013_12_031 crossref_primary_10_1681_ASN_2020091319 crossref_primary_10_1146_annurev_med_042220_022745 crossref_primary_10_1097_HCR_0000000000000481 crossref_primary_10_1002_ehf2_13382 crossref_primary_10_1161_CIRCULATIONAHA_116_024822 crossref_primary_10_1007_s10741_020_09996_y crossref_primary_10_1016_j_amjcard_2020_03_006 crossref_primary_10_1016_j_echo_2022_03_006 crossref_primary_10_1016_j_pcad_2022_10_005 crossref_primary_10_1016_j_ccl_2022_07_001 crossref_primary_10_1016_j_jchf_2015_01_010 crossref_primary_10_1002_ejhf_2093 crossref_primary_10_1016_j_jchf_2016_03_011 crossref_primary_10_1016_j_cardfail_2020_12_025 crossref_primary_10_1016_j_echo_2018_12_002 crossref_primary_10_1016_j_jchf_2015_12_013 crossref_primary_10_4330_wjc_v12_i1_7 crossref_primary_10_1016_j_ejim_2014_09_017 crossref_primary_10_1093_ehjci_jeae152 crossref_primary_10_1161_CIRCHEARTFAILURE_114_001966 crossref_primary_10_1016_j_jchf_2018_06_002 crossref_primary_10_1161_HYPERTENSIONAHA_111_00163 |
| ContentType | Journal Article |
| Copyright | Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.jacc.2011.02.055 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1558-3597 |
| ExternalDocumentID | 21737017 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: R37 AG018915 – fundername: NIA NIH HHS grantid: R01 AG012257 – fundername: NIA NIH HHS grantid: R01AG12257 – fundername: NCRR NIH HHS grantid: MO1RR07122 – fundername: NIA NIH HHS grantid: R37AG18915 – fundername: NIA NIH HHS grantid: R01 AG018915 – fundername: NCRR NIH HHS grantid: M01 RR007122 – fundername: NHLBI NIH HHS grantid: T32 HL076132 – fundername: NIA NIH HHS grantid: P30AG21332 – fundername: NHLBI NIH HHS grantid: 5T32HL076132-02 |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ AABNK AABVL AAEDT AAEDW AAIKJ AAKUH AALRI AAOAW AAQFI AAXUO ABBQC ABFNM ABFRF ABLJU ABMAC ABOCM ABWVN ABXDB ACGFO ACGFS ACIUM ACJTP ACPRK ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFCTW AFETI AFFNX AFPUW AFRAH AFRHN AFTJW AGCQF AGHFR AGYEJ AHMBA AIGII AITUG AJRQY AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BLXMC CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EFKBS EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FNPLU G-Q GBLVA GX1 H13 HVGLF HZ~ IHE IXB J1W K-O KQ8 L7B MO0 N9A NPM O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 RIG ROL RPZ SCC SDF SDG SDP SES SSZ TR2 UNMZH UV1 W8F WH7 WOQ WOW YYM YZZ Z5R 7X8 EFLBG ~HD |
| ID | FETCH-LOGICAL-c607t-45cd1ec41ef71ddf2e3f0f8c96e794c9f043c8aad556a860575f67910d43cf112 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 343 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000292453200008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1558-3597 |
| IngestDate | Sun Nov 09 05:32:25 EST 2025 Mon Jul 21 05:50:57 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-45cd1ec41ef71ddf2e3f0f8c96e794c9f043c8aad556a860575f67910d43cf112 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.clinicalkey.com/#!/content/1-s2.0-S0735109711015476 |
| PMID | 21737017 |
| PQID | 875722546 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_875722546 pubmed_primary_21737017 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-07-12 |
| PublicationDateYYYYMMDD | 2011-07-12 |
| PublicationDate_xml | – month: 07 year: 2011 text: 2011-07-12 day: 12 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of the American College of Cardiology |
| PublicationTitleAlternate | J Am Coll Cardiol |
| PublicationYear | 2011 |
| References | 21737018 - J Am Coll Cardiol. 2011 Jul 12;58(3):275-7. doi: 10.1016/j.jacc.2011.02.054. 22133861 - J Am Coll Cardiol. 2011 Dec 6;58(24):2547-8; author reply 2548-9. doi: 10.1016/j.jacc.2011.08.048. |
| References_xml | – reference: 22133861 - J Am Coll Cardiol. 2011 Dec 6;58(24):2547-8; author reply 2548-9. doi: 10.1016/j.jacc.2011.08.048. – reference: 21737018 - J Am Coll Cardiol. 2011 Jul 12;58(3):275-7. doi: 10.1016/j.jacc.2011.02.054. |
| SSID | ssj0006819 |
| Score | 2.534523 |
| Snippet | The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak Vo(2)) in patients with heart failure with preserved... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 265 |
| SubjectTerms | Aged Cardiac Output Echocardiography Exercise Test Exercise Tolerance Female Heart Failure - diagnostic imaging Heart Failure - physiopathology Humans Male Oxygen - blood Oxygen Consumption Stroke Volume Ventricular Function, Left |
| Title | Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21737017 https://www.proquest.com/docview/875722546 |
| Volume | 58 |
| WOSCitedRecordID | wos000292453200008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_Vhf5OA12kfSJCcRdfHgLntQ2FvJJhlZWdp1WwX_vUmbVS_iwUsphUDJTCZfMt_Mh9C5O3JZPga3viVlhHLGiBJSkQiEZVwZmkBTKPzABwMxGslh4OZUgVa5iIlNoDal9nfkl77xeuKbt1_NXokXjfLJ1aCgsYw6qUMyntHFR9_NwjPR6Hq4HVOQ1AHnUDPT0rtelNahg2dyETH2O8Jsdpre5j__cQttBIiJr1uf2EZLtthBa_2QRN9Fz7c_KDC4BLyQXcKToi6n1ktt-HdsvYL39AN70esag5p4CjsOnVgr7K9wsefRetKkwfalYXUVGOZtscQeeurdPd7ck6C3QHQW8ZpQpk1sNY0t8NgYSGwKzmZaOnNKqiVENNVCKcNYpkTmkR5k3OEN476DA277aKUoC3uIsMqAxtxmdiwVtYoJI50zqJhpKShA2kV4MYO582efpFCFLd-q_GsOu-igtUI-a_tu5O70lHIXQY7-HnyM1tvLX07i5AR1wK1le4pW9Xs9qeZnjZ-452DY_wTW3soJ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determinants+of+exercise+intolerance+in+elderly+heart+failure+patients+with+preserved+ejection+fraction&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Haykowsky%2C+Mark+J&rft.au=Brubaker%2C+Peter+H&rft.au=John%2C+Jerry+M&rft.au=Stewart%2C+Kathryn+P&rft.date=2011-07-12&rft.issn=1558-3597&rft.eissn=1558-3597&rft.volume=58&rft.issue=3&rft.spage=265&rft_id=info:doi/10.1016%2Fj.jacc.2011.02.055&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-3597&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-3597&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-3597&client=summon |